Gilead Sciences, Inc. (LON:0QYQ)

Gilead Sciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	111,541	91,952	79,247	89,366	67,265	53,490
Market Cap Growth	25.28%	16.03%	-11.32%	32.86%	25.75%	-13.83%
Enterprise Value	122,181	105,107	91,636	104,039	82,020	55,161
Last Close Price	90.21	71.41	59.27	63.38	46.60	34.92
PE Ratio	18.49	239.83	17.82	23.45	14.63	593.74
PS Ratio	5.15	4.00	3.72	3.95	3.34	2.96
PB Ratio	6.99	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	16.36	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	15.51	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.67	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.53	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.51	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	17.93	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	16.14%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	5.41%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	6.11%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	2.01%	3.45%	3.97%	3.82%	4.50%	5.71%
Payout Ratio	49.10%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	0.99%	3.68%	4.29%	3.90%	4.58%	6.80%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.